Evans DG*, Evans G*
Evans DG*, Evans G*
University of Manchester
E-mail confirmado em mft.nhs.uk
Título
Citado por
Citado por
Ano
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
American journal of human genetics 72 (5), 1117, 2003
37802003
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
25012007
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
16512002
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L van’t Veer, JE Garber, ...
Journal of Clinical Oncology 22 (6), 1055-1062, 2004
12132004
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
11972010
Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer, A van den Ouweland, J Klijn, M Wasielewski, ...
Nature genetics 31 (1), 55-59, 2002
1183*2002
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ...
Lancet 365 (9473), 1769, 2005
11352005
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans, ME Baser, J McGaughran, S Sharif, E Howard, A Moran
Journal of medical genetics 39 (5), 311-314, 2002
10342002
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
SR Cairns, JH Scholefield, RJ Steele, MG Dunlop, HJW Thomas, ...
Gut 59 (5), 666-689, 2010
9882010
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
9852013
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ...
Nature genetics 39 (2), 165-167, 2007
9532007
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in …
SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, ...
Journal of clinical oncology 20 (9), 2310-2318, 2002
9272002
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
8762011
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24. 21
I Tomlinson, E Webb, L Carvajal-Carmona, P Broderick, Z Kemp, S Spain, ...
Nature genetics 39 (8), 984-988, 2007
8512007
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ...
Journal of medical genetics 44 (2), 81-88, 2007
8432007
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, ...
Nature 464 (7289), 713, 2010
8092010
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ...
Jama 317 (23), 2402-2416, 2017
7912017
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
J Cuzick, JF Forbes, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, ...
The Lancet 360, 817-824, 2002
7832002
Oral contraceptives and the risk of hereditary ovarian cancer
SA Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, ...
New England Journal of Medicine 339 (7), 424-428, 1998
7581998
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature Genetics, 2012
7382012
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20